Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Issues New COVID-19 EUA Requirements After HHS Restores Agency’s LDT Oversight Role

Nov 16 2021

• By Elizabeth Orr

FDA entrance sign 2016

Related Content

Recall Of Millions Of Ellume COVID-19 Tests High-Risk Class I, FDA Says

Nov 10 2021

Patient Advocacy Groups Pressure US Lawmakers To Pass VALID Act For Diagnostics Regulation

Jul 02 2021

Override: HHS Revokes FDA’s LDT Policies

Aug 20 2020

Additional Topics

United States Coronavirus COVID-19 Policy Politics Review Pathway FDA Regulation Medical Device Diagnostics

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window